Transfemoral aortic valve-in-valve implantation with the CoreValve evolut for small degenerated stented bioprosthesis

Journal of Invasive Cardiology

Volumn 26, Issue 6, 2014, Pages 291-294

  Jategaonkar, Smita R ^a   Scholtz, Werner ^a   Horstkotte, Dieter ^a   Gummert, Jan ^b   Ensminger, Stephan M ^b   Börgermann, Jochen ^b  

^a Department of Cardiology ^*  (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

aortic valve disease; bioprosthesis; transcatheter aortic valve implantation

Indexed keywords

AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; ARTICLE; CASE REPORT; COHORT ANALYSIS; FOLLOW UP; HIGH RISK PATIENT; HUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS AORTIC VALVE; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTA VALVE; BIOPROSTHESIS; DEVICES; FEMORAL ARTERY; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEART VALVE REPLACEMENT; HEMODYNAMICS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; STENT; TREATMENT OUTCOME; VERY ELDERLY;

AGED, 80 AND OVER; AORTIC VALVE; BIOPROSTHESIS; FEMORAL ARTERY; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 84902465451     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137(1): 82-90.
2. Glower DD, Landolfo KP, Cheruvu S, et al. Determinants of 15-year outcome with 1,119 standard Carpentier-Edwards porcine valves. Ann Thorac Surg. 1998;66(6 Suppl):S44-S48. (Pubitemid 29087128)
3. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013;145(1): 6-23.
4. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50(1): 69-76.
5. Vahanian A, Alfieri O, Al-Attar N, et al European Association of Cardio-Thoracic Surgery; European Society of Cardiology; European Association of Percutaneous Cardiovascular Interventions. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29(11): 1463-1470.
6. Ferrari E. Transapical aortic 'valve-in-valve' procedure for degenerated stented bioprosthesis. Eur J Cardiothorac Surg. 2012;41(3): 485-490.
7. Bedogni F, Laudisa ML, Pizzocri S, et al. Transcatheter valve-in-valve implantation using CoreValve Revalving System for failed surgical aortic bioprostheses. JACC Cardiovasc Interv. 2011;4(11): 1228-1234.
8. Eggebrecht H, Schäfer U, Treede H, et al. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv. 2011;4(11): 1218-1227.
9. Azadani AN, Jaussaud N, Matthews PB, Ge L, Chuter TA, Tseng EE. Transcatheter aortic valves inadequately relieve stenosis in small degenerated bioprostheses. Interact Cardiovasc Thorac Surg. 2010;11(1): 70-77.
10. Gurvitch R, Cheung A, Bedogni F, Webb JG. Coronary obstruction following transcatheter aortic valve-in-valve implantation for failed surgical bioprostheses. Catheter Cardiovasc Interv. 2011;77(3): 439-444.
11. Dvir D, Webb J, Brecker S, Bleiziffer S, et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation. 2012;126(19): 2335-2344.
12. Hernández-García JM, Muñoz-García AJ, Alonso-Briales JH, et al. Percutaneous treatment of a dysfunctional aortic bioprosthesis with the CoreValve prosthesis. Rev Esp Cardiol. 2011;64(2): 155-158.
13. Webb J. Balloon valvuloplasty for stenotic bioprosthetic aortic valves. Catheter Cardiovasc Interv. 2011;77(4):593.
14. Vahanian A, Baumgartner H, Bax J, et al; Task force on the management of valvular heart disease of the European Society of Cardiology; ESC Committee for Practice Guidelines (2007). Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J. 2007;28(2): 230-268.
15. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol. 2006;48(3):e1-e148.